A detailed history of Shufro Rose & CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Shufro Rose & CO LLC holds 4,000 shares of NVS stock, worth $393,800. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$393,800
Previous $425,000 8.24%
% of portfolio
0.04%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

SELL
$80.03 - $92.81 $3,201 - $3,712
-40 Reduced 0.99%
4,000 $368,000
Q4 2022

Jan 25, 2023

SELL
$75.55 - $92.52 $3,022 - $3,700
-40 Reduced 0.98%
4,040 $0
Q3 2022

Oct 24, 2022

BUY
$74.61 - $87.26 $2,984 - $3,490
40 Added 0.99%
4,080 $310,000
Q2 2022

Jul 22, 2022

SELL
$80.52 - $93.75 $16,104 - $18,750
-200 Reduced 4.72%
4,040 $342,000
Q3 2021

Nov 05, 2021

SELL
$81.78 - $95.14 $32,712 - $38,056
-400 Reduced 8.62%
4,240 $347,000
Q1 2021

Apr 28, 2021

SELL
$83.5 - $98.47 $44,088 - $51,992
-528 Reduced 10.22%
4,640 $397,000
Q4 2020

Feb 03, 2021

BUY
$78.07 - $94.43 $1,014 - $1,227
13 Added 0.25%
5,168 $488,000
Q3 2020

Oct 27, 2020

BUY
$82.14 - $91.0 $16,428 - $18,200
200 Added 4.04%
5,155 $448,000
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $905,327 - $1.11 Million
-12,007 Reduced 70.79%
4,955 $452,000
Q3 2018

Oct 26, 2018

BUY
$66.94 - $77.43 $21,755 - $25,164
325 Added 1.95%
16,962 $1.46 Million
Q2 2018

Jul 27, 2018

SELL
$64.91 - $73.36 $12,008 - $13,571
-185 Reduced 1.1%
16,637 $1.26 Million
Q1 2018

May 04, 2018

SELL
$70.39 - $84.15 $28,156 - $33,660
-400 Reduced 2.32%
16,822 $1.36 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1.28 Million - $1.33 Million
17,222
17,222 $1.48 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Shufro Rose & CO LLC Portfolio

Follow Shufro Rose & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.